Stay updated on HY209 Gel Phase I Clinical Trial
Sign up to get notified when there's something new on the HY209 Gel Phase I Clinical Trial page.

Latest updates to the HY209 Gel Phase I Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe footer now displays Revision: v3.4.2, replacing the previous v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedOnly a site revision update from v3.4.0 to v3.4.1 is visible, with no changes to study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedAdded a glossary toggle; updated several UI labels for capitalization (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'); and updated the footer revision from v3.3.4 to v3.4.0. These are formatting and metadata updates that do not modify study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now shows an updated site revision line: Revision: v3.3.4 (replacing v3.3.3). This is a minor metadata update and does not affect the clinical trial details, eligibility criteria, enrollment, or results.SummaryDifference0.1%

- Check76 days agoChange DetectedAdded: Revision: v3.3.3 and removed: HHS Vulnerability Disclosure and Revision: v3.3.2. The changes pertain to site-wide release notes/footer and do not affect the Study Details content or its purpose.SummaryDifference0.1%

- Check104 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to HY209 Gel Phase I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HY209 Gel Phase I Clinical Trial page.